Therapeutic potential of antisense oligonucleotides as modulators of alternative splicing
An estimated 60% of all human genes undergo alternative splicing, a highly regulated process that produces splice variants with different functions. Such variants have been linked to a variety of cancers, and genetic diseases such as thalassemia and cystic fibrosis. This Perspective describes a prom...
Guardat en:
| Publicat a: | J Clin Invest |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
American Society for Clinical Investigation
2003
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC171400/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/12925686/ https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI19547 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|